Financial Performance - The company's revenue for the year was approximately HKD 19.5 million, a decrease of about 46.5% compared to HKD 36.5 million for the fiscal year ending March 31, 2023[16]. - The company reported an improved loss of HKD 91.2 million for the year, compared to a loss of approximately HKD 332.9 million in the previous fiscal year[16]. - The environmental consulting services segment contributed approximately HKD 19.5 million in revenue, down about 43.8% from HKD 34.7 million in the previous fiscal year[26]. - Sales in the health products segment recorded approximately HKD 20,000, a significant decline of about 98.8% from HKD 1.6 million in the previous fiscal year[28]. - The group's revenue for the year was approximately HKD 19.5 million, a decrease of about 46.5% compared to HKD 36.5 million in the fiscal year 2023[57]. - The group recorded a sales cost of approximately HKD 9.6 million, a decrease of about 61.2% from HKD 24.8 million in the fiscal year 2023, primarily due to a reduction in business scale[60]. - The group's gross profit decreased by approximately 15.0% to HKD 9.9 million from HKD 11.6 million in the fiscal year 2023, attributed to a reduction in business scale without a corresponding decrease in labor costs[63]. - The gross profit margin increased from approximately 31.9% in the fiscal year 2023 to about 50.7% in the current year, mainly due to a decrease in sales costs[63]. - The company recorded a net loss of approximately HKD 91.2 million for the year, an improvement from a loss of HKD 332.9 million in the previous fiscal year[70]. - The expected credit loss provision net amount for the year was approximately HKD 9.3 million, with accounts receivable and other receivables contributing about HKD 7.1 million and HKD 2.2 million, respectively, accounting for 76.2% and 23.8% of the total expected credit loss provision[65]. - The group recorded a cumulative expected credit loss provision of approximately HKD 109 million for loans and other receivables under the financial services segment[55]. Operational Challenges - The company experienced a challenging fiscal year due to the lingering effects of the COVID-19 pandemic, which led to continued contraction in various industries, including environmental consulting services[15]. - The company faced operational disruptions as two executive directors were taken by the Shanxi Provincial Commission for Discipline Inspection, impacting business development efforts[15]. - The overall economic environment remains challenging, but the company is committed to maintaining stable revenue sources while reducing operational costs[25]. - The publishing, procurement, and distribution of books have been suspended due to tight cash flow and unfavorable industry conditions, with significant receivables from downstream distributors[29]. - The financing leasing business has been on hold, with plans to resume operations in compliance with new regulations issued by the National Financial Supervisory Administration[31]. - Other financial services, including currency lending and P2P operations, have been permanently ceased due to deteriorating financial conditions of various businesses exacerbated by the COVID-19 pandemic[32]. Future Plans and Strategies - The company plans to prudently assess industry prospects and actively explore new business growth points to improve operational performance in the upcoming fiscal year[16]. - The health products market is expected to grow significantly due to rising disposable income and increased public awareness of health, despite current challenges[24]. - The company is focusing on adjusting raw material sources and improving processing technology to better meet market demands[28]. - The environmental consulting services industry is anticipated to benefit from increased government investment and supportive policies aimed at environmental protection and sustainable development[21]. - The company aims to expand its product offerings to cater to the younger generation's growing interest in health and dietary supplements[28]. - The company plans to launch new health products, including Japanese natto kinase supplements, to expand its product portfolio and attract demand from the younger generation in China[74]. - The company aims to enhance its revenue drivers and overall financial performance amid global political and economic instability[74]. Governance and Compliance - The company is committed to adhering to the GEM listing rules and ensuring the accuracy and completeness of the information provided[8]. - The company has established a dedicated audit committee to oversee financial reporting and compliance[118]. - The board consists of six directors, including one executive director and three independent non-executive directors, ensuring a balance of power and oversight[130]. - The company faced governance challenges due to the resignation of two executive directors in June 2023, which necessitated interim leadership arrangements[133]. - The board has established committees for audit, remuneration, and nominations to enhance governance and oversight[130]. - The company has taken corrective actions to address governance code deviations, including clarifying the roles of the chairman and CEO[135]. - The board is committed to ensuring that independent non-executive directors provide independent opinions and are evaluated annually for their independence[133]. - The company emphasizes maintaining high standards of business ethics and corporate governance as a key objective[123]. - The company has adhered to all applicable provisions of the corporate governance code as outlined in the GEM Listing Rules[124]. Employee and Management Practices - The company emphasizes employee training and development, covering topics such as industry advancements and compliance[107]. - The management team is focused on mitigating business risks by monitoring market trends and employee retention strategies[100]. - The company aims to attract and retain key personnel by offering competitive rewards and ensuring a conducive work environment[100]. - The company has established a clear framework for evaluating board candidates, ensuring they possess relevant business, financial, and management skills[171]. - The company is committed to maintaining gender diversity and equality across its workforce and aims to achieve gender balance in senior management within the next year[164]. - The company has implemented measures to ensure timely and accurate information is provided to all directors for informed decision-making[139]. Financial Position and Liquidity - Current liabilities exceeded current assets by approximately HKD 452,280,000 as of March 31, 2024[192]. - The company has outstanding borrowings of approximately HKD 584,634,000 as of March 31, 2024, with cash and cash equivalents of only about HKD 12,987,000[192]. - The company is taking measures to improve liquidity and financial conditions due to uncertainties regarding going concern, including potential asset impairment adjustments[196]. - The company plans to establish settlement arrangements with creditors, including offsetting loan principal based on court rulings[197]. - Legal actions will be initiated to recover receivables to improve operational cash flow and financial status[197]. - The company is seeking further financing from investors, lenders, and shareholders to enhance liquidity[197]. - Non-core businesses and/or financial assets may be sold to raise operational funds[197]. - The audit committee supports management's position and emphasizes the need to resolve uncertainties related to going concern[198].

Financial Services Segment Performance - The financial services segment recorded zero revenue and an expected credit loss of approximately HKD 147.8 million, accounting for about 20.72% of the total assets as of March 31, 2023[3]. - The outstanding balance of loans and other receivables in the financial services business was approximately HKD 114 million, with an expected total credit loss of HKD 113 million for the year[5]. - The financial services segment remains suspended due to the adverse financial conditions of various industries exacerbated by the COVID-19 pandemic[5]. - The company has not established a specific timeline for the resumption of the financial services segment but will monitor industry conditions and macroeconomic environments closely[5]. Business Models and Operations - The business model prior to suspension included two main modes: currency lending and P2P business, primarily operated by a wholly-owned subsidiary[6]. - The currency lending model focused on providing loans to corporate clients for operational and trading activities, typically secured by third-party guarantees[7]. - The P2P business model was gradually phased out due to deteriorating quality in similar services offered by other providers and increased regulatory scrutiny[11]. - The loan agreements under the currency lending model typically had a term of about 12 months, while P2P loans ranged from 90 to 180 days[12]. - The company emphasizes compliance with applicable Chinese laws and regulations during the operation of the P2P business model[11]. Credit Risk Management - The credit risk assessment policy requires all clients in the financial services segment to undergo a thorough evaluation and background check[14]. - As of March 31, 2023, the group has 19 debtors across various industries, with outstanding loans totaling approximately HKD 0.1 million to HKD 21 million, and applicable interest rates ranging from 7% to 9%[23]. - The top five debtors account for approximately 81% of the total outstanding loans[23]. - The group recorded a cumulative expected credit loss provision of approximately HKD 113 million for the financial services segment, fully provisioning for loans under the P2P business model[27]. Loan Monitoring and Recovery - The financial department is responsible for monitoring the loan portfolio and individual loan recoverability, including assessing the actual use of loans and the financial condition of borrowers[20]. - The group has established internal monitoring measures for loan recovery processes and will take appropriate follow-up actions if any potential difficulties in repayment are identified[19]. - In the event of overdue loans, management will consider appropriate follow-up actions, including legal proceedings against borrowers and guarantors if necessary[22]. - The expected credit loss model is based on a "three-stage model" as per Hong Kong Financial Reporting Standard 9, assessing credit quality changes and estimating economic losses[24]. - The group will initiate legal proceedings against borrowers and/or guarantors for loans under the P2P business model that have been overdue for some time[27]. - The financial department will issue reminders and collection letters for all overdue loans, and may escalate to legal action if necessary[22]. - The group will disclose further updates on legal proceedings and recovery of outstanding receivables as per applicable laws and regulations[27].

Financial Performance - For the six months ended September 30, 2023, the company reported revenue of HKD 9,954,000, a decrease of 49.9% compared to HKD 19,856,000 for the same period in 2022[8]. - The gross profit for the same period was HKD 6,194,000, representing a gross margin of approximately 62.2%, compared to HKD 6,727,000 and a gross margin of 33.8% in the previous year[8]. - The company incurred a loss before tax of HKD 10,484,000, a significant improvement from a loss of HKD 21,418,000 in the prior year[8]. - The net loss attributable to the owners of the company for the six months was HKD 7,623,000, compared to HKD 15,561,000 in the same period last year, indicating a reduction of 51%[8]. - The company reported a total comprehensive loss attributable to owners of the company of HKD 138,000,000 for the six months ended September 30, 2023, compared to a loss of HKD 206,616,000 for the same period in 2022, indicating an improvement in performance[28]. - The group incurred an operating loss of 3,760 thousand HKD for the six months ended September 30, 2023, compared to an operating loss of 13,129 thousand HKD for the same period in 2022, representing a 71.4% improvement[126]. - The company recorded a loss of approximately HKD 10.95 million during the reporting period, an improvement compared to a loss of about HKD 22.36 million in the same period last year[144]. Assets and Liabilities - The company's total assets as of September 30, 2023, were HKD 651,090,000, down from HKD 691,421,000 as of March 31, 2023[12]. - The company reported a decrease in total liabilities to HKD 1,015,812,000 from HKD 1,049,600,000, indicating a reduction in financial obligations[12]. - As of September 30, 2023, the company's total capital deficit amounted to HKD 344,616,000, compared to HKD 336,973,000 as of March 31, 2023, reflecting an increase in capital deficit of approximately 0.4%[14]. - The total borrowings as of September 30, 2023, were HKD 579,261,000, a decrease of approximately 4.3% from HKD 605,431,000 as of March 31, 2023[28]. - The group's total liabilities were approximately HKD 1,008.63 million, with a debt level of HKD 579.26 million, down from HKD 605.43 million as of March 31, 2023, reflecting a decrease of about 4.31%[159]. - The group's accounts receivable amounted to 621,064 thousand HKD, down from 640,641 thousand HKD as of March 31, 2023, indicating a decrease of 3.0%[120]. Cash Flow and Liquidity - The company reported a net cash generated from operating activities of HKD 3,270,000 for the six months ended September 30, 2023, compared to a net cash used of HKD 2,433,000 for the same period in 2022, indicating a significant turnaround[23]. - The company's cash and cash equivalents increased to HKD 12,951,000 from HKD 8,880,000, reflecting improved liquidity[12]. - The cash and cash equivalents at the end of the period were HKD 12,951,000, down from HKD 15,123,000 at the end of the same period last year, representing a decrease of approximately 14.4%[23]. - The group's cash and bank balances increased from HKD 8.88 million as of March 31, 2023, to HKD 12.95 million as of September 30, 2023, due to improved cash flow from operations[164]. Operational Efficiency and Strategy - The company continues to focus on improving operational efficiency and reducing costs to enhance profitability in future periods[5]. - The management remains optimistic about future growth opportunities despite the current market challenges[5]. - The company plans to reassess its strategy in the health product sales division and integrate new product supply chains to introduce more attractive health products to the Chinese market[138]. - The group anticipates a gradual recovery of the Chinese economy in the last quarter of 2023 and the first half of 2024, driven by increased consumer spending and industrial investment[147]. - The group plans to leverage its strategic positioning and product acquisition channels to capture market opportunities during the economic recovery[147]. Corporate Governance - The company has established an audit committee to review and oversee the financial reporting process and internal control procedures, consisting of non-executive directors and independent non-executive directors[195]. - The interim chairman confirmed that all directors have complied with the company's adopted code of conduct for securities trading, which meets the standards set by GEM listing rules[194]. - The company emphasizes the importance of good corporate governance practices and procedures, with the chairman responsible for ensuring these are established[200]. - The board of directors is composed of both executive and independent non-executive directors, ensuring a balanced governance structure[196]. - The company has taken steps to clarify the division of responsibilities between the chairman and CEO[180]. Market Trends - The environmental consulting services industry is expected to see significant growth due to increased demand for environmental consulting services driven by enhanced regulatory requirements and policies[35]. - The market for ecological restoration and comprehensive utilization of mining solid waste is experiencing a surge in demand, supported by new projects and innovative business models[37]. - The demand for health products remains strong, with a notable shift towards high-quality and diverse options as disposable income increases in China[40]. - The sales of imported health products are projected to grow significantly due to rising public health awareness and the demand for quality supplements[40].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任 何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 DADI INTERNATIONAL GROUP LIMITED 大 地 國 際 集 團 有 限 公司 （於開曼群島註冊成立並於百慕達存續之有限公司） （股份代號：8130） 截至二零二三年九月三十日止六個月之 中期業績公告 大地國際集團有限公司（「本公司」）董事（「董事」）會（「董事會」）欣然宣佈本公司 及其附屬公司截至二零二三年九月三十日止六個月的未經審核綜合業績。本公告 載列本公司二零二三年中期報告（「中期報告」）全文，符合香港聯合交易所有限公 司GEM證券上市規則有關隨附各財政年度首六個月之初步業績公告資料的相關 規定。 本業績公告將分別在香港聯合交易所有限公司（「聯交所」）網站(www.hkexnews.hk) 及本公司網站(http://www.dadi-international.com.hk)上刊登。 中期報告印刷本將寄發予本公司股東，並於適當時間在聯交所網站及本公司網站 可供查閱。 承 ...

Financial Performance - For the three months ended June 30, 2023, the company reported revenue of HKD 5,686,000, a decrease of 53.5% compared to HKD 12,240,000 for the same period in 2022[11] - The cost of sales for the same period was HKD 3,008,000, resulting in a gross profit of HKD 2,678,000, down from HKD 4,164,000 in 2022[11] - The company incurred an operating loss of HKD 297,000 for the three months ended June 30, 2023, compared to an operating loss of HKD 2,811,000 in the previous year[11] - The total loss for the period was HKD 5,310,000, significantly reduced from HKD 11,011,000 in the same period of 2022[12] - Basic and diluted loss per share for the three months ended June 30, 2023, was HKD 0.11, an improvement from HKD 0.21 in 2022[11] - Other income and gains for the period amounted to HKD 1,951,000, a substantial increase from HKD 225,000 in the previous year[11] - The group reported a loss attributable to owners of approximately HKD 5.31 million for the period, an improvement from a loss of approximately HKD 11.01 million in the same period of 2022[26] Expenses and Costs - Administrative expenses decreased to HKD 4,926,000 from HKD 7,200,000, reflecting a reduction of 31.6%[11] - The group recorded a financial cost of approximately HKD 4.91 million, a decrease of about 39.29% compared to HKD 8.09 million for the three months ended June 30, 2022[26] - The cumulative income tax expense for the three months ended June 30, 2023, was approximately HKD 105,000, compared to HKD 115,000 in 2022[46] - The group’s administrative expenses and financial costs decreased overall due to the uncertain economic environment, despite a reduction in revenue from environmental consulting services[26] - Administrative expenses decreased by approximately 31.58% to about HKD 4.93 million from approximately HKD 7.20 million in the same period last year[51] - The group has implemented cost-saving measures due to the challenging business environment in China and the lack of investment from market participants[51] Market and Strategic Outlook - The group aims to introduce more attractive and advanced health products and nutritional supplements from overseas to the domestic market in China[20] - The group is reassessing its strategy for the health product sales division in light of the current market conditions[20] - The group anticipates a gradual recovery of the Chinese economy in the last quarter of 2023 and the first half of 2024, leading to increased demand for environmental consulting services[58] - The group aims to expand its health product market in response to rising consumer awareness and demand for healthy lifestyles, particularly among the younger generation[58] - The group will continue to focus on developing its core business and strategically expanding its operational scale while monitoring industry developments and government policies[58] Operational Challenges - The group’s operating environment faced challenges due to increased borrowing costs and inflation in overseas countries, impacting investment motivation[27] - The group believes the impact of the COVID-19 pandemic will be temporary and remains optimistic about the long-term development of the Chinese economy[27] - The group’s revenue from environmental consulting services was affected by a temporary decrease in investment motivation from project owners[26] Corporate Governance - The weighted average number of shares issued was 3,640,627,457 for both 2023 and 2022, indicating no change in share count[19] - The company has not made any provisions for Hong Kong profits tax due to tax losses being fully offset, consistent with the previous year[18] - The company did not declare any interim dividend for the three months ended June 30, 2023, compared to none in the same period of 2022[20] - The group has not redeemed any of its listed securities during the period[62] - The audit committee has reviewed the group's unaudited consolidated financial statements for the period[62] - The board of directors consists of one executive director, two non-executive directors, and three independent non-executive directors[63] - The report date is August 11, 2023[64]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 DADI INTERNATIONAL GROUP LIMITED 大 地 國 際 集 團 有 限 公司 （於開曼群島註冊成立並於百慕達存續之有限公司） （股份代號：8130） 截至二零二三年六月三十日止三個月之 第一季度業績公告 大地國際集團有限公司（「本公司」）董事（「董事」）會（「董事會」）欣然宣佈本公司 及其附屬公司截至二零二三年六月三十日止三個月的未經審核綜合業績。本公告 載列本公司二零二三年第一季度報告（「第一季度報告」）全文，符合香港聯合交易 所有限公司（「聯交所」）GEM證券上市規則有關隨附初步季度業績公告資料的相 關規定。 本 業 績 公 告 將 分 別 在 聯 交 所 網 站 (www.hkexnews.hk) 及 本 公 司 網 站 (http://www.dadi-international.com.hk)上刊登。 第一季度報告印刷本將寄發予本公司股東，並於適當時間在聯交所網站及本公 ...

Financial Performance - The company reported a revenue of approximately HKD 36.5 million for the fiscal year, a decrease of about 3.9% compared to HKD 38.0 million in the previous fiscal year[17]. - The sales of health products reached approximately HKD 1.6 million, representing a significant increase of about 497.1% from HKD 0.3 million in the previous fiscal year[14]. - The gross profit margin decreased from approximately 48.7% in the previous fiscal year to about 31.9% in the current year, primarily due to reduced revenue from the publishing segment and increased direct costs in environmental consulting services[20]. - The environmental consulting services segment contributed approximately HKD 34.7 million in revenue, remaining stable compared to the previous fiscal year[24]. - The group recorded a sales cost of approximately HKD 24.8 million for the year, representing a year-on-year increase of about 27.4% compared to HKD 19.5 million in the 2022 fiscal year[29]. - Gross profit decreased from approximately HKD 18.5 million in the 2022 fiscal year to HKD 11.6 million this year, a decline of about 37.0%[30]. - The group reported a loss of approximately HKD 332.9 million for the year, an improvement from a loss of HKD 378.5 million in the 2022 fiscal year[31]. - The asset-liability ratio increased to approximately 147.2%, up from 97.6% as of March 31, 2022, primarily due to a significant reduction in current assets[40]. - The group recognized an expected credit loss provision of approximately HKD 265.4 million for the year, reflecting impairment losses on receivables and deposits[41]. - The group recorded a significant decrease in total assets, approximately HKD 713.3 million as of March 31, 2023, down from HKD 1,085.0 million as of March 31, 2022, representing a decline of about 34.3%[50]. Cost Management and Expenses - The financial costs for the company were approximately HKD 49.3 million, a decrease of about 6.1% from HKD 52.5 million in the previous fiscal year, mainly due to exchange rate differences[21]. - Administrative expenses decreased by approximately 31.5% from HKD 44.9 million in the 2022 fiscal year to HKD 30.8 million this year[41]. - Cost-saving measures implemented due to a challenging business environment have led to a reduction in administrative expenses and improved loss conditions[31]. Strategic Initiatives and Future Plans - The company plans to increase resource investment in environmental consulting services, green mining restoration, and ecological protection to drive business growth in the upcoming fiscal year[9]. - The company is exploring new opportunities in the health product sales market, particularly targeting the younger generation with functional snacks and dietary supplements[14]. - The group anticipates continued growth in demand for its environmental consulting services due to increased public awareness and policy support for environmental initiatives[32]. - The group is considering expanding procurement from new overseas jurisdictions, such as the United States, and introducing new products like Japanese natto kinase supplements[32]. - The group is actively exploring ecological and environmental projects in regions such as Shandong, Shanxi, Shaanxi, and Hainan through government guidance and market operations[32]. - The group aims to enhance its revenue drivers and overall financial performance by focusing on strategic emerging industries such as renewable energy and biomedical sectors in the upcoming year[46]. Legal and Compliance Matters - The company is actively pursuing legal actions against downstream distributors to recover outstanding receivables as part of its efforts to maintain liquidity and financial stability[26]. - The group has recognized expected credit loss provisions for the year, particularly related to other receivables and deposits from borrowers/guarantors in the suspended financial services business[51]. - The group is actively pursuing legal actions to recover outstanding amounts from borrowers/guarantors in China[50]. Governance and Board Structure - The board consists of eight directors, including three executive directors and three independent non-executive directors, with no changes in composition during the year[143]. - The company has established three board committees: audit committee, remuneration committee, and nomination committee to oversee specific areas of governance[142]. - The company emphasizes the importance of independent non-executive directors in providing independent opinions and contributions to the board[144]. - The board believes that the current ratio of executive to non-executive directors is reasonable and sufficient to safeguard the interests of shareholders and the company[154]. - The company has taken corrective actions to address governance code deficiencies, including ensuring the separation of roles between the chairman and the CEO[145]. - The nomination committee reviewed the board's structure, size, and diversity during the year, assessing the independence of non-executive directors[173]. Employee and Workplace Culture - The company emphasizes a culture of employee development, workplace safety, and sustainable growth strategies[85]. - The company employed approximately 73 employees, a decrease from 99 employees as of March 31, 2022[126]. - Over 90% of the employees are full-time, with more than 60% aged between 31 and 50 years, indicating a commitment to retaining junior staff[197]. - The company aims to achieve gender diversity and equality in its senior management team within the next two years[197]. - The management team is committed to attracting and retaining top talent to build a strong and efficient workforce[85]. Shareholder Communication and Dividends - The board does not recommend any final dividend for the current year, consistent with the previous fiscal year[47]. - The company has not changed its shareholder communication policy, which allows for unimpeded communication of shareholder opinions to the board[163]. - The company will not distribute the final dividend for the fiscal year 2022 and the interim dividend for the current year[195].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 DADI INTERNATIONAL GROUP LIMITED 大 地 國 際 集 團 有 限 公司 （於開曼群島註冊成立並於百慕達存續之有限公司） （股份代號：8130） 公 告 截至二零二三年三月三十一日止年度之年度業績 大地國際集團有限公司（「本公司」）董事（「董事」）會（「董事會」）謹此宣佈本公司 及其附屬公司截至二零二三年三月三十一日止年度的經審核業績。本公告載列本 公司截至二零二三年三月三十一日止年度的年報（「年報」）全文，符合香港聯合交 易所有限公司（「聯交所」）GEM證券上市規則有關隨附初步年度業績公告資料的 相關規定。 刊登年度業績及年報 本 業 績 公 告 將 分 別 在 聯 交 所 網 站 (www.hkexnews.hk) 及 本 公 司 網 站 (http://www.dadi-international.com.hk)上刊登。 本公司將於適當時候向本公司股份持有人寄發年報， ...

Financial Performance - Revenue for Q3 2022 was HKD 12,306,000, an increase of 14.8% compared to HKD 10,715,000 in Q3 2021[6] - Gross profit for Q3 2022 was HKD 2,724,000, down 38.3% from HKD 4,426,000 in Q3 2021[6] - Operating loss for Q3 2022 was HKD 3,210,000, an improvement from a loss of HKD 8,369,000 in Q3 2021[6] - The net loss for Q3 2022 was HKD 835,000, compared to a net loss of HKD 19,933,000 in Q3 2021[6] - Total administrative expenses for Q3 2022 were HKD 3,646,000, significantly reduced from HKD 12,897,000 in Q3 2021[6] - The company reported a basic and diluted loss per share of HKD 0.02 for Q3 2022, compared to a loss of HKD 0.38 in Q3 2021[6] - For the nine months ended December 31, 2022, revenue was HKD 32,162,000, up 7.1% from HKD 30,028,000 in the same period of 2021[6] - The company experienced a total comprehensive loss of HKD 1,174,000 for Q3 2022, compared to a loss of HKD 22,615,000 in Q3 2021[13] - The financial cost for Q3 2022 was HKD 2,389,000, a significant decrease from HKD 11,811,000 in Q3 2021[6] - The company incurred a net loss of HKD 14,824,000 for the nine months ended December 31, 2022, compared to a loss of HKD 40,500,000 in the same period of 2021, indicating an improvement in financial performance[27] Revenue Sources and Business Focus - The company is focused on expanding its business in publishing, procurement, and financial services[9] - For the three months ended December 31, 2022, the company reported customer contract revenue of HKD 11,541,000, an increase from HKD 10,695,000 in the same period of 2021, representing a growth of approximately 7.9%[20] - The environmental consulting services division contributed approximately HKD 31,028,000 in revenue, representing a growth of 13.66% compared to HKD 27,300,000 in the same period last year[32] - The healthcare products division recorded sales of approximately HKD 1,029,000, with a loss of about HKD 730,000, as it began operations in the second half of the previous year[34] - The publishing, procurement, and distribution division generated revenue of approximately HKD 105,000, a significant decrease from HKD 2,700,000 in the same period last year[35] - The company plans to invest more resources in expanding its environmental consulting services and diversifying revenue sources[42] - The company aims to enhance its healthcare product offerings by collaborating with overseas and local technical and product development institutions[46] Shareholder Information - As of December 31, 2022, the major shareholders hold a total of 1,027,985,995 shares, representing 28.24% of the company's issued share capital[51] - Mr. Zhang Xiongfeng holds 237,209,900 shares, which is 6.52% of the company's issued share capital[48] - Mr. Wu Xiaoming holds 41,240,000 shares, accounting for 1.13% of the company's issued share capital[48] Corporate Governance - The audit committee has been established to oversee the financial reporting process, risk management, and internal control procedures[55] - No arrangements were made for directors or senior management to profit from purchasing the company's securities[49] - There are no known competitive interests among directors and major shareholders that could affect the company's business[53] - The board consists of three executive directors, two non-executive directors, and three independent non-executive directors[56] Financial Reporting and Standards - The company has not adopted any new accounting standards that would have a significant impact on its financial statements for the period[3] - The company did not repurchase any of its listed securities during the reporting period[54] - The company has not purchased or sold any of its listed securities during the reporting period[54] - The board of directors decided not to declare any interim dividend for the nine months ended December 31, 2022, consistent with the previous year[30] Operational Challenges and Resilience - The company emphasized resilience in its overall business performance despite challenges posed by the COVID-19 pandemic, focusing on supporting its environmental business segment, which is a major source of revenue[31] - The company's operating loss for the three months ended December 31, 2022, was HKD 9,582,000, compared to an operating loss of HKD 6,289,000 in the same period of 2021, indicating a deterioration in performance[22] - The total financial expenses for the nine months ended December 31, 2022, amounted to HKD 12,682,000, a decrease from HKD 38,307,000 in the same period of 2021, showing a significant reduction of approximately 66.9%[23] - Administrative expenses decreased by approximately 53% to about HKD 16,922,000 from HKD 36,353,000 in the same period last year[40] - Financial expenses for the period were approximately HKD 12,682,000, a decrease of about 67% from HKD 38,307,000 in the previous year[44] - The company reported a loss attributable to owners of approximately HKD 14,824,000, a reduction of about 63.4% compared to HKD 40,500,000 in the same period last year[45] - The company will focus on recovering outstanding receivables from industry counterparts to restore normal operations in the publishing division[46]

Financial Performance - For the six months ended September 30, 2022, the company reported a revenue of HKD 19,856,000, a slight increase from HKD 19,313,000 in the same period of 2021, representing a growth of 2.8%[5] - The gross profit for the same period was HKD 6,727,000, compared to HKD 10,662,000 in 2021, indicating a decrease of 37.3%[5] - The company incurred a loss of HKD 22,360,000 for the six months ended September 30, 2022, an improvement from a loss of HKD 38,979,000 in the previous year, reflecting a reduction of 42.5%[5] - The basic and diluted loss per share for the period was HKD 0.43, compared to HKD 0.73 in the same period of 2021, showing a decrease of 41.1%[5] - The company reported a net loss of (HKD 175,271,000) for the six months ended September 30, 2022, compared to a net loss of (HKD 20,779,000) for the same period in 2021, indicating a worsening financial performance[15] - The company reported a total loss of 15,561,000 HKD for the six months ended September 30, 2022, which is a 41.2% reduction compared to a loss of 26,499,000 HKD in the same period of 2021[55] Assets and Liabilities - Total assets as of September 30, 2022, were HKD 930,011,000, down from HKD 1,028,814,000 as of March 31, 2022, a decline of 9.6%[9] - The company's non-current assets decreased from HKD 56,159,000 as of March 31, 2022, to HKD 40,859,000 as of September 30, 2022, a drop of 27.3%[9] - Current liabilities decreased from HKD 1,058,671,000 to HKD 966,981,000, reflecting a reduction of 8.6%[9] - The total assets of the company as of September 30, 2022, were HKD 2,084,681,000, compared to HKD 1,877,731,000 as of March 31, 2022, showing a growth of approximately 11%[15] - The company's total liabilities as of September 30, 2022, were 878,258 thousand HKD, down from 975,203 thousand HKD as of March 31, 2022, indicating a decrease of 9.9%[59] - The company's cash and cash equivalents were HKD 15,123,000 as of September 30, 2022, compared to HKD 16,854,000 as of March 31, 2022, a decrease of 10.3%[9] Cash Flow and Investments - As of September 30, 2022, the company reported a net cash flow from operating activities of (HKD 2,433,000), compared to (HKD 10,142,000) for the same period in 2021, indicating a significant improvement in cash flow management[15] - The company generated cash inflow from investment activities amounting to HKD 1,600,000 in the first half of 2022, down from HKD 4,788,000 in the previous year, reflecting a decrease in investment returns[15] - The cash and cash equivalents at the end of the reporting period were HKD 15,123,000, down from HKD 24,806,000 at the end of the previous year, representing a decrease of approximately 39%[15] Revenue Segments - The company’s revenue from its publishing and distribution segment in China is a key focus area, contributing significantly to overall performance[22] - The environmental business generated revenue of 7,362 thousand HKD for the three months ended September 30, 2022, up 8.3% from 6,791 thousand HKD in the same period last year[41] - The environmental consulting services segment contributed approximately HKD 19.49 million in revenue, with a growth of about 17.13% compared to HKD 16.64 million in the previous year[81] Expenses and Cost Management - The company incurred total operating expenses of 4,382 thousand HKD for the three months ended September 30, 2022, down 26.2% from 5,940 thousand HKD in the same period last year[46] - Financial expenses decreased by approximately 9.10% to HKD 15.07 million, down from HKD 26.5 million in the previous year[87] - Administrative expenses were reduced by approximately 43.39% to about HKD 13.28 million, compared to HKD 23.46 million in the same period last year[87] Market Opportunities and Growth - The company is exploring expansion opportunities in the environmental consulting services sector in China, aiming to enhance its service offerings[22] - The environmental services industry is expected to grow due to government policies aimed at enhancing ecological protection and radiation safety management[71] - The demand for radiation monitoring services is anticipated to increase significantly with the expansion of 5G networks and the installation of numerous communication base stations[72] - The company is positioned to benefit from the growing market potential in radiation monitoring and environmental assessments related to renewable energy projects in Shanxi Province[74] - The health food market in China is projected to reach approximately RMB 320 billion by 2023, showing significant growth potential[78] Corporate Governance - The company emphasizes strong corporate governance principles to enhance accountability and transparency to shareholders[117] - The company has complied with the corporate governance code as per GEM Listing Rules during the reporting period[117] - The board of directors consists of three executive directors and four non-executive directors, ensuring a diverse governance structure[121]